Emerging Growth Companies raise money by selling shares, debentures etc. Do you actually think their going to close up shop because they need money? Are you serious?

The number of shares outstanding is miniscule compared to the vast majority of companies. This emerging growth company is entering a billion dollar plus field and issuing shares is the way to go to raise money.

80 million shares outstanding doesn't bother me in the least and I hope the they sell whatever they need to finish the testing and begin the FDA testing and finalize the entry of their products into the market place.

Again 80 million shares outstanding is nothing campared to the shares outstanding in the medical field.